Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Research

Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey

Authors: Aslınur Albayrak, Halil Demirbaş

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Older adults often use multiple medicines to manage comorbidities well or to prevent associated complications. This study aims to determine polypharmacy, the use of potentially inappropriate medications (PIMs) using the 2019 Beers Criteria and to determine the Medication Regimen Complexity Index (MRCI) score. It also aims to identify factors associated with the presence of PIMs and the MRCI score.

Methods

This cross-sectional study was carried out between 6 and 2023 and 5 May 2023 in a community pharmacy in Turkey. Elderly patients over 65 years of age, who used at least one drug, and who came to the pharmacy for any reason were included in the study. PIMs were determined according to the 2019 Beers Criteria. The Turkish validated version of the MRCI was used to determine the medication complexity score.

Results

200 patients were included in this study. 59.5% of the patients were female and the median age was 70 (IQR, 66-74.75). Polypharmacy was detected in 33% of patients. The use of PIMs was determined in 63.5% of the patients. The median of the MRCI score was 11 (IQR, 7–15). The number of chronic diseases and drugs, presence of polypharmacy, MRCI score and mental disorders were found to be significantly higher in those with PIMs than in those without (p < 0.05). Having less than eight years of education, presence of polypharmacy, the presence of comorbidity (diabetes mellitus, cardiovascular disease, thyroid, chronic obstructive pulmonary disease (COPD), asthma and mental disorders) were associated with significantly higher MRCI scores (p < 0.05).

Conclusions

According to the results of our study, it was found that the elderly patients who came to the pharmacy had low MRCI scores, but had high PIMs use. Community pharmacists have an important role in identifying inappropriate drug use, so they should be trained to develop skills in identifying and reducing PIMs in older patients.
Literature
1.
go back to reference Jirón M, Pate V, Hanson LC, Lund JL, Jonsson Funk M, Stürmer T. Trends in prevalence and determinants of potentially inappropriate prescribing in the United States: 2007 to 2012. J Am Geriatr. 2016;64(4):788–97. Jirón M, Pate V, Hanson LC, Lund JL, Jonsson Funk M, Stürmer T. Trends in prevalence and determinants of potentially inappropriate prescribing in the United States: 2007 to 2012. J Am Geriatr. 2016;64(4):788–97.
2.
go back to reference Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.
3.
go back to reference He D, Zhu H, Zhou H, Dong N, Zhang H. Potentially inappropriate medications in Chinese older adults: a comparison of two updated Beers criteria. Int J Clin Pharm. 2021;43:229–35.PubMed He D, Zhu H, Zhou H, Dong N, Zhang H. Potentially inappropriate medications in Chinese older adults: a comparison of two updated Beers criteria. Int J Clin Pharm. 2021;43:229–35.PubMed
4.
go back to reference Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:2042098619829431.PubMedPubMedCentral Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:2042098619829431.PubMedPubMedCentral
5.
go back to reference American Geriatrics Society. 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94. American Geriatrics Society. 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94.
6.
go back to reference Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–32.PubMed Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–32.PubMed
7.
go back to reference American Geriatrics Society. 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023. American Geriatrics Society. 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023.
8.
go back to reference Hagstrom K, Nailor M, Lindberg M, Hobbs L, Sobieraj DM. Association between potentially inappropriate medication use in elderly adults and hospital-related outcomes. J Am Geriatr Soc. 2015;63(1):185–86.PubMed Hagstrom K, Nailor M, Lindberg M, Hobbs L, Sobieraj DM. Association between potentially inappropriate medication use in elderly adults and hospital-related outcomes. J Am Geriatr Soc. 2015;63(1):185–86.PubMed
9.
go back to reference Praxedes MFS, Pereira GCS, Lima CFM, Santos DBd, Berhends JS. Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review. Cien Saude Colet. 2021;26:3209–19.PubMed Praxedes MFS, Pereira GCS, Lima CFM, Santos DBd, Berhends JS. Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review. Cien Saude Colet. 2021;26:3209–19.PubMed
10.
go back to reference Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271–77.PubMed Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271–77.PubMed
11.
go back to reference Chahine B. Potentially inappropriate medications prescribing to elderly patients with advanced chronic kidney by using 2019 American Geriatrics Society Beers Criteria. Health Sci Rep. 2020;3(4):e214.PubMedPubMedCentral Chahine B. Potentially inappropriate medications prescribing to elderly patients with advanced chronic kidney by using 2019 American Geriatrics Society Beers Criteria. Health Sci Rep. 2020;3(4):e214.PubMedPubMedCentral
12.
go back to reference Xu Z, Liang X, Zhu Y, Lu Y, Ye Y, Fang L et al. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021;9(4). Xu Z, Liang X, Zhu Y, Lu Y, Ye Y, Fang L et al. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021;9(4).
13.
go back to reference Alhmoud E, Khalifa S, Bahi AA. Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm. 2015;37:815–21.PubMed Alhmoud E, Khalifa S, Bahi AA. Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm. 2015;37:815–21.PubMed
14.
go back to reference Zeenny R, Wakim S, Kuyumjian Y-M. Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging. 2017:65–73. Zeenny R, Wakim S, Kuyumjian Y-M. Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging. 2017:65–73.
15.
go back to reference Advinha AM, de Oliveira-Martins S, Mateus V, Pajote SG, Lopes MJ. Medication regimen complexity in institutionalized elderly people in an aging society. Int J Clin Pharm. 2014;36:750–56.PubMed Advinha AM, de Oliveira-Martins S, Mateus V, Pajote SG, Lopes MJ. Medication regimen complexity in institutionalized elderly people in an aging society. Int J Clin Pharm. 2014;36:750–56.PubMed
16.
go back to reference Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.PubMed Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.PubMed
17.
go back to reference Advinha AM, Lopes MJ, de Oliveira-Martins S. Assessment of the elderly’s functional ability to manage their medication: a systematic literature review. Int J Clin Pharm. 2017;39:1–15.PubMed Advinha AM, Lopes MJ, de Oliveira-Martins S. Assessment of the elderly’s functional ability to manage their medication: a systematic literature review. Int J Clin Pharm. 2017;39:1–15.PubMed
18.
go back to reference Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm. 2015;37:327–34.PubMed Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm. 2015;37:327–34.PubMed
19.
go back to reference Falch C, Alves G. Pharmacists’ role in older adults’ medication regimen complexity: a systematic review. Int J Environ Res Public Health. 2021;18(16):8824.PubMedPubMedCentral Falch C, Alves G. Pharmacists’ role in older adults’ medication regimen complexity: a systematic review. Int J Environ Res Public Health. 2021;18(16):8824.PubMedPubMedCentral
20.
go back to reference Kelley SO. Measurement of the complexity of medication regimens of the elderly. University of Missouri-Columbia; 1988. Kelley SO. Measurement of the complexity of medication regimens of the elderly. University of Missouri-Columbia; 1988.
21.
go back to reference DiIorio C, Yeager K, Shafer PO, Letz R. The Epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155.PubMed DiIorio C, Yeager K, Shafer PO, Letz R. The Epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155.PubMed
22.
go back to reference DiIorio C, McDonnell M, McCarty F, Yeager K. Initial testing of the antiretroviral medication complexity index. J Assoc Nurses AIDS Care. 2006;17(1):26–36.PubMed DiIorio C, McDonnell M, McCarty F, Yeager K. Initial testing of the antiretroviral medication complexity index. J Assoc Nurses AIDS Care. 2006;17(1):26–36.PubMed
23.
go back to reference George J, Phun Y-T, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.PubMed George J, Phun Y-T, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.PubMed
24.
go back to reference Okuyan B, Babi B, Sancar M, Ay P, Yücel E, Yücel A, et al. Validation of the Turkish version of medication regimen complexity index among elderly patients. J Eval Clin Pract. 2016;22(5):732–36.PubMed Okuyan B, Babi B, Sancar M, Ay P, Yücel E, Yücel A, et al. Validation of the Turkish version of medication regimen complexity index among elderly patients. J Eval Clin Pract. 2016;22(5):732–36.PubMed
25.
go back to reference Alves-Conceição V, Rocha KSS, Silva FVN, Silva RdOS, Cerqueira-Santos S, Nunes MAP, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54(4):301–13.PubMed Alves-Conceição V, Rocha KSS, Silva FVN, Silva RdOS, Cerqueira-Santos S, Nunes MAP, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54(4):301–13.PubMed
26.
go back to reference Abou-Karam N, Bradford C, Lor KB, Barnett M, Ha M, Rizos A. Medication regimen complexity and readmissions after hospitalization for Heart Failure, acute Myocardial Infarction, Pneumonia, and Chronic Obstructive Pulmonary Disease. SAGE Open Med. 2016;4:2050312116632426.PubMedPubMedCentral Abou-Karam N, Bradford C, Lor KB, Barnett M, Ha M, Rizos A. Medication regimen complexity and readmissions after hospitalization for Heart Failure, acute Myocardial Infarction, Pneumonia, and Chronic Obstructive Pulmonary Disease. SAGE Open Med. 2016;4:2050312116632426.PubMedPubMedCentral
27.
go back to reference Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48(1):26–32.PubMed Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48(1):26–32.PubMed
28.
go back to reference Kuo SZ, Haftek M, Lai JC. Factors associated with medication non-adherence in patients with end-stage Liver Disease. Dig Dis Sci. 2017;62:543–49.PubMed Kuo SZ, Haftek M, Lai JC. Factors associated with medication non-adherence in patients with end-stage Liver Disease. Dig Dis Sci. 2017;62:543–49.PubMed
29.
go back to reference Wimmer BC, Johnell K, Fastbom J, Wiese MD, Bell JS. Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71:1099–108.PubMed Wimmer BC, Johnell K, Fastbom J, Wiese MD, Bell JS. Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71:1099–108.PubMed
30.
go back to reference Herson M, Bell J, Tan E, Emery T, Robson L, Wimmer B. Factors associated with medication regimen complexity in residents of long-term care facilities. Eur Geriatr Med. 2015;6(6):561–64. Herson M, Bell J, Tan E, Emery T, Robson L, Wimmer B. Factors associated with medication regimen complexity in residents of long-term care facilities. Eur Geriatr Med. 2015;6(6):561–64.
31.
go back to reference Bužančić I, Kummer I, Držaić M, Ortner Hadžiabdić M. Community-based pharmacists’ role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452–63.PubMed Bužančić I, Kummer I, Držaić M, Ortner Hadžiabdić M. Community-based pharmacists’ role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452–63.PubMed
32.
go back to reference Yakar M, Özgür EM. Türkiye’de Nüfus Yaşlanması, Yerel Düzeyde Tehlike Çanları Çalıyor. Coğrafya Derg. 2022(44):231–50. Yakar M, Özgür EM. Türkiye’de Nüfus Yaşlanması, Yerel Düzeyde Tehlike Çanları Çalıyor. Coğrafya Derg. 2022(44):231–50.
35.
go back to reference Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443–52.PubMedPubMedCentral Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443–52.PubMedPubMedCentral
36.
go back to reference Chiapella LC, Montemarani Menna J, Mamprin ME. Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation. Int J Clin Pharm. 2018;40:987–90.PubMed Chiapella LC, Montemarani Menna J, Mamprin ME. Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation. Int J Clin Pharm. 2018;40:987–90.PubMed
37.
go back to reference Blozik E, Rapold R, von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30:561–68.PubMed Blozik E, Rapold R, von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30:561–68.PubMed
38.
go back to reference Tan YW, Suppiah S, Bautista MAC, Malhotra R. Polypharmacy among community-dwelling elderly in Singapore: prevalence, risk factors and association with medication non-adherence. Proc Singap Healthc. 2019;28(4):224–31. Tan YW, Suppiah S, Bautista MAC, Malhotra R. Polypharmacy among community-dwelling elderly in Singapore: prevalence, risk factors and association with medication non-adherence. Proc Singap Healthc. 2019;28(4):224–31.
39.
go back to reference Sayın Z, Sancar M, Özen Y, Okuyan B. Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting. Acta Clin Belg. 2022;77(2):273–79.PubMed Sayın Z, Sancar M, Özen Y, Okuyan B. Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting. Acta Clin Belg. 2022;77(2):273–79.PubMed
40.
go back to reference Öztürk GZ, Ardic C, Toprak D. Frequency of polypharmacy and use of potentially inappropriate medications in the elderly. Turk J Geriatr. 2017;20(4). Öztürk GZ, Ardic C, Toprak D. Frequency of polypharmacy and use of potentially inappropriate medications in the elderly. Turk J Geriatr. 2017;20(4).
41.
go back to reference Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28(2):159–72.PubMed Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28(2):159–72.PubMed
42.
go back to reference Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–8.PubMed Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–8.PubMed
43.
go back to reference Anand P, Katyal J, Dey AB, Gupta YK. Characterization of potentially inappropriate medications use in Indian elderly population and their impact on quality of life using Beers criteria. Aging Med. 2022;5(1):45–52. Anand P, Katyal J, Dey AB, Gupta YK. Characterization of potentially inappropriate medications use in Indian elderly population and their impact on quality of life using Beers criteria. Aging Med. 2022;5(1):45–52.
44.
go back to reference Alhawassi TM, Alatawi W, Alwhaibi M. Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatr. 2019;19(1):1–8. Alhawassi TM, Alatawi W, Alwhaibi M. Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatr. 2019;19(1):1–8.
45.
go back to reference Oliveira MG, Amorim WW, de Jesus SR, Rodrigues VA, Passos LC. Factors associated with potentially inappropriate medication use by the elderly in the Brazilian primary care setting. Int J Clin Pharm. 2012;34:626–32.PubMed Oliveira MG, Amorim WW, de Jesus SR, Rodrigues VA, Passos LC. Factors associated with potentially inappropriate medication use by the elderly in the Brazilian primary care setting. Int J Clin Pharm. 2012;34:626–32.PubMed
46.
go back to reference Lin Y-J, Peng L-N, Chen L-K, Lin M-H, Hwang S-J. Risk factors of potentially inappropriate medications among older patients visiting the community health center in rural Taiwan. Arch Gerontol Geriatr. 2011;53(2):225–28.PubMed Lin Y-J, Peng L-N, Chen L-K, Lin M-H, Hwang S-J. Risk factors of potentially inappropriate medications among older patients visiting the community health center in rural Taiwan. Arch Gerontol Geriatr. 2011;53(2):225–28.PubMed
47.
go back to reference Luo H, Fan Q, Bian T, Li X, Chen K, Zhang Q, et al. Awareness, attitude and behavior regarding Proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv Res. 2019;19:1–9. Luo H, Fan Q, Bian T, Li X, Chen K, Zhang Q, et al. Awareness, attitude and behavior regarding Proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv Res. 2019;19:1–9.
48.
go back to reference Alves-Conceição V, Silva DTd S, VLd S, EGd, Santos LMC, Lyra DP. Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study. BMC Pharmacol Toxicol. 2017;18(1):1–8. Alves-Conceição V, Silva DTd S, VLd S, EGd, Santos LMC, Lyra DP. Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study. BMC Pharmacol Toxicol. 2017;18(1):1–8.
49.
go back to reference Lee S, Jang J, Yang S, Hahn J, Min KL, Jung E, et al. Development and validation of the Korean version of the medication regimen complexity index. PLoS ONE. 2019;14(5):e0216805.PubMedPubMedCentral Lee S, Jang J, Yang S, Hahn J, Min KL, Jung E, et al. Development and validation of the Korean version of the medication regimen complexity index. PLoS ONE. 2019;14(5):e0216805.PubMedPubMedCentral
50.
go back to reference Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract. 2015;13(4). Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract. 2015;13(4).
51.
go back to reference Pantuzza LL, Ceccato MGB, Silveira MR, Pinto IV, Reis AMM. Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care. Geriatr Gerontol Int. 2018;18(6):853–59.PubMed Pantuzza LL, Ceccato MGB, Silveira MR, Pinto IV, Reis AMM. Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care. Geriatr Gerontol Int. 2018;18(6):853–59.PubMed
52.
go back to reference Van Mil JF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harv Health Policy Rev. 2006;7(1):155–68. Van Mil JF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harv Health Policy Rev. 2006;7(1):155–68.
53.
go back to reference Ergün Y, Aykan DA. Akılcı İlaç Kullanımında Genel İlkeler. Arşiv Kaynak Tarama Derg. 2019;28(1):19–27. Ergün Y, Aykan DA. Akılcı İlaç Kullanımında Genel İlkeler. Arşiv Kaynak Tarama Derg. 2019;28(1):19–27.
Metadata
Title
Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
Authors
Aslınur Albayrak
Halil Demirbaş
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04381-4

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine